Status:
COMPLETED
Comparison of Standard Isolation With Targeted Isolation for Preventing Nosocomial Transmission of MRSA and VRE
Lead Sponsor:
Vanderbilt University Medical Center
Conditions:
MRSA
VRE Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hospital-acquired infections are common and frequently lead to poor outcomes, including death, in affected patients. Two common organisms that cause infections in the hospital are methicillin-resistan...
Detailed Description
CONTACT-PILOT is a single center, pilot, multiple crossover, cluster-randomized trial of contact isolation for MRSA and VRE in the Vanderbilt Medical Intensive Care Unit (MICU) in order to determine i...
Eligibility Criteria
Inclusion
- All adult patients admitted to the study ICU, the Vanderbilt University Medical Center Medical Intensive Care Unit, during an active enrollment period
Exclusion
- Age less than 18 years old
- Patients admitted during a run-in period
Key Trial Info
Start Date :
September 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2018
Estimated Enrollment :
1974 Patients enrolled
Trial Details
Trial ID
NCT03268122
Start Date
September 1 2017
End Date
May 30 2018
Last Update
June 14 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37209